The challenges facing a medtech start-up  in developing new markets –  technology, standards,  trials and reimbursement Mi...
<ul><li>Patents in </li></ul><ul><li>Electrode chemistry, physics and electrophysiology 2001 </li></ul><ul><li>Pulse Wave ...
 
welcomes The world’s first intelligent, wearable,  non-invasive, wireless device monitoring  the patient’s vital signs rem...
<ul><li>300 million people in Europe and the US have at least one chronic disease that may benefit from home health monito...
Our focus is on improving the quality of care for aging and ill populations  while delivering compelling cost advantages a...
Our Products
Vitalsens V-Patch wireless monitor measuring 3-lead ecg, heart rate, and detecting cardiac arrhythmias regulatory approval...
Vitalsens V-Patch wireless monitor measuring 3-lead ecg, heart rate, and detecting cardiac arrhythmias
Vitalsens Aingeal  in-hospital wi-fi monitor measuring ecg, heart rate, respiration rate, temperature and motion in an amb...
The Competition
The Trials
Vitalsens March 2010 Trial 1
Aingeal General Purpose In-Hospital  Monitor - July 2010 A clinical trial using the Aingeal monitor began in Massachusetts...
Trial 3 AMNCH Hospital Dublin V-Patch used to monitor cardiac patients at home http:// canberra.intelesens.com /Demo/
Technology Phase Trials and Testing  Phase Adoption, Reimbursement and Procurement  Phase Marketing  and Sales Phase Ulste...
 
In-hospital, wireless vital signs monitor At-home, wireless vital signs monitor temp resp pulse ox ecg motion Delays and a...
Upcoming SlideShare
Loading in …5
×

Micheal Caulfield

1,135 views

Published on

The Challenges of Developing New Markets for a Start-Up - Technology, Trials, Standards and Ethics.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,135
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • WHAT IS THE HEALTHCARE CHALLENGE?
  • Who are your competitors? How strong are they? Are they well funded? How many are there? What are the relative strengths against your solution? It may useful to show a competitor matrix showing how benefits/features of your product/technology compares
  • TO SUMMARISE
  • Micheal Caulfield

    1. 1. The challenges facing a medtech start-up in developing new markets – technology, standards, trials and reimbursement Michael Caulfield – CEO Intelesens Ltd
    2. 2. <ul><li>Patents in </li></ul><ul><li>Electrode chemistry, physics and electrophysiology 2001 </li></ul><ul><li>Pulse Wave Velocity 2001 </li></ul><ul><li>Breath Gas Detection ppb 2001 </li></ul><ul><li>Biometric algorithm 2008 </li></ul><ul><li>Blood oxygenation 2008 </li></ul><ul><li>Electrode topology 2007 </li></ul><ul><li>Electromechanical fastening 2008 </li></ul><ul><li>Monitoring system 2002 </li></ul><ul><li>ECG accelerometer 2009 </li></ul><ul><li>Non-patented IP </li></ul><ul><li>ECG arrhythmia detection and identification algorithms </li></ul>
    3. 4. welcomes The world’s first intelligent, wearable, non-invasive, wireless device monitoring the patient’s vital signs remotely www.intelesens.com
    4. 5. <ul><li>300 million people in Europe and the US have at least one chronic disease that may benefit from home health monitoring. </li></ul><ul><li>US and Europe market size for home health monitoring of chronic diseases > $11 billion last year </li></ul><ul><li>Problem is growing at 10 percent per year </li></ul><ul><li>25 percent of that population would benefit from existing home monitoring solutions currently available, while some 50 percent would benefit from integrating or connecting existing medical devices with their mobile phones. </li></ul><ul><li>- Berg Insight </li></ul>EU and US The Market
    5. 6. Our focus is on improving the quality of care for aging and ill populations while delivering compelling cost advantages and benefits for healthcare providers Our value proposition
    6. 7. Our Products
    7. 8. Vitalsens V-Patch wireless monitor measuring 3-lead ecg, heart rate, and detecting cardiac arrhythmias regulatory approval 2009 regulatory approval 2011
    8. 9. Vitalsens V-Patch wireless monitor measuring 3-lead ecg, heart rate, and detecting cardiac arrhythmias
    9. 10. Vitalsens Aingeal in-hospital wi-fi monitor measuring ecg, heart rate, respiration rate, temperature and motion in an ambulatory patient regulatory approval 2011 regulatory approval 2010
    10. 11. The Competition
    11. 12. The Trials
    12. 13. Vitalsens March 2010 Trial 1
    13. 14. Aingeal General Purpose In-Hospital Monitor - July 2010 A clinical trial using the Aingeal monitor began in Massachusetts General Hospital in Boston in July 2010 The Aingeal device will be used in a surgical ward and will measure ecg, heart rate, respiration rate, temperature and motion. It communicates with patient records database via the hospital’s wi-fi network Trial 2
    14. 15. Trial 3 AMNCH Hospital Dublin V-Patch used to monitor cardiac patients at home http:// canberra.intelesens.com /Demo/
    15. 16. Technology Phase Trials and Testing Phase Adoption, Reimbursement and Procurement Phase Marketing and Sales Phase Ulster MGH Tallaght
    16. 18. In-hospital, wireless vital signs monitor At-home, wireless vital signs monitor temp resp pulse ox ecg motion Delays and avoids ward admissions Expedites hospital discharge ecg SpO 2 temp resp motion

    ×